CDH23, variants, traits, and what the research shows

CDH23 - what this gene does

CDH23 is a human gene whose variants are most consistently flagged in hearing-related research. The on-file variant data also links it to rare disease and cancer phenotypes (observable traits or conditions), though hearing is the dominant signal across the highest-priority entries.

Key takeaways

• The majority of this gene's highest-priority variants are linked to hearing traits
• Smaller clusters of variants are flagged for rare disease and cancer associations
• Over 2,300 variants have been recorded for this gene, indicating a broad research footprint
• All listed variants represent population-level statistical associations, not personal health predictions
• Detailed effect sizes and replication data are not yet available in this record

Notable variants

Among the 20 highest-priority variants on file, 14 carry hearing-related trait labels: rs1039517349, rs1057520662, rs1060499793, rs11000008, rs111033247, rs111033369, rs111033453, rs111033457, rs111033458, rs111033461, rs111033480, rs111033483, rs111033488, and rs111033490. Three variants - rs1057520661, rs1064795044, and rs111033489 - are flagged for rare disease associations, while rs1060499714, rs111033270, and rs111033487 carry cancer trait labels. All 20 share a uniform magnitude score of 5.50.

Trait associations

Hearing is the dominant trait category: 14 of the 20 highest-priority variants on file carry hearing-related labels, and this clustering across multiple independent variant entries strengthens the signal. Rare disease associations are represented by rs1057520661, rs1064795044, and rs111033489, and cancer associations by rs1060499714, rs111033270, and rs111033487. The full database holds 2,354 variants for this gene; 27 carry prior research summaries whose content will expand this picture once incorporated.

Evidence quality

No per-variant research summaries are currently available, which prevents reporting of individual effect sizes - such as odds ratios (a measure of how much a variant changes the odds of a trait) or beta coefficients (the estimated size of a continuous effect) - or sample sizes and replication status. The 20 highest-priority variants all share a magnitude score of 5.50, reflecting uniform evidence weighting in the current dataset, but the basis for that weighting cannot be detailed without underlying summaries. This record should be treated as a preliminary trait-signal overview; the 27 pending summaries will substantially deepen the evidence base when loaded.

What this is NOT

The associations described here are population-level statistical signals from genetic research - they are not deterministic predictors of any individual's health or outcomes. Nothing in this entry constitutes medical advice, a diagnosis, or a recommendation of any kind.